Armata Pharmaceuticals (ARMP) Buy Rating Reiterated at HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Performance NYSEAMERICAN ARMP opened at $3.91 on Friday. The company has a market cap of $141.35 million, […]
HC Wainwright restated their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Up 1.4 % Shares of ARMP opened at $3.74 on Friday. The stock has a market […]
Core royalty platform on track; received GSK royalties of $69.6 million for fourth quarter
Achieved net product revenues of $19.7 million for the fourth quarter of 2023 representing 35% year on.